Driving Legislative Change for Access to Medications.
An insurance company denied coverage for an inflammatory bowel disease medication, stating that the lack of a pediatric Food and Drug Administration indication made that treatment experimental. This was legally permissible. The patient's pediatric gastroenterologist partnered with others to create a new state law that...